Verbindung oder Zusammensetzung damit zur Verwendung bei der Behandlung oder Prävention von Übergewicht und Adipositas und zur Gewichtskontrolle Und/oder -Kontrolle

Details

Veröffentlichungs-Nr.

EP4796112

Anmeldetag

19. Februar 2025

Veröffentlichung

26. August 2026

Rechtsraum

EP

IPC

A61K31/16, A61K33/06, A61P3/04

Abstract

The present invention relates to a compound or a composition comprising the same for use in the treatment or in the prevention of overweightness, of obesity and/or of the overweightness and the obesity associated metabolic disfunctions or disorders and/or of the overweightness and the obesity associated noncommunicable diseases (NCDs).The present invention also relates to a use, in particular to a non-therapeutic use, of a compound or of a composition comprising the same, for managing / controlling weight, for controlling obesity, for controlling normal weight, for controlling overweightness, for supporting weight loss, for supporting weight maintenance, for suppressing food intake, for reducing appetite, for increasing lipolysis and/or for reducing / controlling weight gain.

Anmelder

Firma

Synapharm Industrial Synthesis

Land

🇧🇪 Belgien

Fachgebiete